PHR3429
Vigabatrin
certified reference material, pharmaceutical secondary standard
Manufacturer: Supelco
CAS Number: 68506-86-5
Synonym(S): (±)-Vigabatrin, (R,S)-4-Amino-5-hexenoic acid, (±)-γ-Vinyl-GABA, (±)-4-Aminohexenoic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 400 MG | PHR3429-400-MG | In Stock | ₹ 33,611.63 |
PHR3429 - 400 MG
In Stock
Quantity
1
Base Price: ₹ 33,611.63
GST (18%): ₹ 6,050.093
Total Price: ₹ 39,661.723
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to BP BP563traceable to Ph. Eur. Y0001400traceable to USP 1712001
CofA
current certificate can be downloaded
packaging
pkg of 400 mg
application(s)
pharmaceutical
SMILES string
NC(CCC(O)=O)C=C
InChI
1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)
InChI key
PJDFLNIOAUIZSL-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences (+/-)-Vigabatrin | 68506-86-5 | MFCD00274577 | 10 mg | -- | ₹ 13,083.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Vigabatrin United States Pharmacopeia (USP) Reference Standard | 68506-86-5 | MFCD00274577 | 200MG | -- | ₹ 67,317.82 | ||
Vigabatrin | -- | ₹ 58,498.30 | ||
Vigabatrin | -- | ₹ 23,944.90 | ||
68506-86-5 | (±)-4-aminohex-5-enoic acid | -- | ₹ 3,560.00 - ₹ 27,323.00 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
- Biochem/physiol Actions: Irreversible GABA transaminase inhibitor. Increases intracellular concentration of GABA in nerve endings; possesses antiepileptic activity.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
STOT RE 1
Target Organs
Eyes,Central nervous system
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable